Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C19H21NO5S |
| Molecular Weight | 375.439 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(OC)=C(C=C1)C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O
InChI
InChIKey=NHFIAAAMCYVRIW-UHFFFAOYSA-N
InChI=1S/C19H21NO5S/c1-11-8-15(21)18(19(22)25-11)14-10-17(26-7-6-20-14)13-5-4-12(23-2)9-16(13)24-3/h4-5,8-9,17,21H,6-7,10H2,1-3H3
KF-38789 is a selective inhibitor of P-selectin-mediated cell adhesion (IC50 = 1.97 uM) that displays no effects on L-selectin- and E-selectin-mediated adhesion. KF-38789 inhibits P-selectin-dependent
cell adhesion, superoxide production by
human PMN and TG-induced cell migration into the murine
peritoneal cavity. It was also identified as a tubulin disruptor.
Originator
Approval Year
Sample Use Guides
Mice: KF-38789 (1 mg/kg) was injected intravenously prior to TG injection and at 3 h following initial injection. Intravenously injected KF-38789 significantly inhibited the TG-induced accumulation of leukocytes in the mouse peritoneal cavity.
Route of Administration:
Intravenous
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SD6U8X7NAE
Created by
admin on Sat Dec 16 11:00:23 GMT 2023 , Edited by admin on Sat Dec 16 11:00:23 GMT 2023
|
PRIMARY | |||
|
257292-29-8
Created by
admin on Sat Dec 16 11:00:23 GMT 2023 , Edited by admin on Sat Dec 16 11:00:23 GMT 2023
|
PRIMARY | |||
|
135400439
Created by
admin on Sat Dec 16 11:00:23 GMT 2023 , Edited by admin on Sat Dec 16 11:00:23 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
